HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonist.

Abstract
A total of 82 patients (74 girls, 8 boys) are presently participating in an international multicentre trial for treatment of central precocious puberty (CPP) with a slow release gonadotropin-releasing hormone (GnRH) agonist depot preparation: Decapeptyl-Depot (DD). Of these patients, 53 (3 boys) were previously untreated (group 1) and 29 (5 boys) have been treated before with either a short-acting GnRH analogue or cyproterone acetate (group 2). Fifty-one patients (44 girls, 7 boys) were treated with DD for 12 months or more. Basal plasma luteinizing hormone (LH) levels decreased in both groups after 1 year of therapy. The LH response to intravenous GnRH was reduced in both groups. Basal plasma follicle stimulating hormone (FSH) levels decreased in both groups. Stimulated FSH levels were reduced in both groups after 1 year of DD treatment. Plasma oestradiol levels in the girls decreased to prepubertal levels in both groups. In all patients the clinical signs of precocious gonadarche such as breast development and menstruations (girls) and an increased testis volume (boys), did not further progress and sometimes regressed in several patients. Growth velocity decreased in the girls of group 1 from 9.0 +/- 0.72 cm/year (mean +/- SEM) in the last half-year before treatment to 6.3 +/- 0.50 in the first half-year of treatment (P less than 0.01) and to 4.5 +/- 0.23 cm/year in the second half-year (P less than 0.01). After 12 months a stabilization of growth velocity was observed.(ABSTRACT TRUNCATED AT 250 WORDS)
AuthorsW Oostdijk, R Hümmelink, R J Odink, C J Partsch, S L Drop, F Lorenzen, W G Sippell, E A van der Velde, H Schultheiss
JournalEuropean journal of pediatrics (Eur J Pediatr) Vol. 149 Issue 5 Pg. 308-13 (Feb 1990) ISSN: 0340-6199 [Print] Germany
PMID2138079 (Publication Type: Journal Article)
Chemical References
  • Delayed-Action Preparations
  • Triptorelin Pamoate
  • Gonadotropin-Releasing Hormone
  • Dehydroepiandrosterone
  • Dehydroepiandrosterone Sulfate
  • Luteinizing Hormone
  • Follicle Stimulating Hormone
Topics
  • Body Height (drug effects)
  • Child
  • Child, Preschool
  • Dehydroepiandrosterone (analogs & derivatives, blood)
  • Dehydroepiandrosterone Sulfate
  • Delayed-Action Preparations
  • Female
  • Follicle Stimulating Hormone (blood)
  • Gonadotropin-Releasing Hormone (administration & dosage, analogs & derivatives, pharmacology, therapeutic use)
  • Humans
  • Injections, Intramuscular
  • Luteinizing Hormone (blood)
  • Male
  • Puberty, Precocious (drug therapy)
  • Triptorelin Pamoate

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: